Lung TB: Higher Dose Of Rifampicin Safe, Can Boost Recurrence-Free Survival, Says ICMR Study
New Delhi: A higher dose of rifampicin -- a bactericidal antibiotic used primarily to treat tuberculosis (TB) -- may be ...
New Delhi: A higher dose of rifampicin -- a bactericidal antibiotic used primarily to treat tuberculosis (TB) -- may be ...
New Delhi: The Indian Council of Medical Research (ICMR) has detected two cases of the Human Metapneumovirus (HMPV) in Karnataka ...
New Delhi: The Indian Council of Medical Research (ICMR) has released 32 new Standard Treatment Workflows (STWs) for common and ...
New Delhi: Calling for accelerated action against antimicrobial resistance (AMR), global experts, including from India, at the 77th World Health ...
New Delhi: The Indian Council of Medical Research (ICMR) has rejected a recent study led by Banaras Hindu University (BHU), ...